Junsang YooCEO at Stand Up Therapeutics Inc.Speaker
Profile
Education
- 2006.08 - 2011.05
B.S in Biochemistry Virginia Tech., Blacksburg, USA
- 2013.08 - 2019.06
Ph.D. and Post Doc in Biomedical engineering, Dongguk University, S. Korea
Professional Experience
- 2019.06 - 2020.08
Invited Researcher Neurodegenerative disease researcher of KIST Center for Neuroscience
- 2021.01 - present
Chief Scientist and CEO in Standup Therapeutics.
- 2023 - present
Frontier Publishing Group publishing editor
Research Interests
Gene Therapy, Cell fate conversion, Cell resetting technology, Epigenetics
Honors & Awards (Maximum 3)
2016
Nominated promising young-scientist researcher in Korea Society for Stem Cell Research (KSSCR)
2018
International Conference Korean society for molecular and cellular biology (KSMCB)
TAKARA best research award
2018
Best research article award in KSMCB
Publications (Maximum 3)
- Yoo J*, Electromagnetized gold nanoparticles mediate direct lineage reprogramming into induced dopamine neurons in vivo for Parkinson's disease therapy. Nature Nanotechnology. 2017 Oct;12(10):1006-1014. (IF:43.341)
- Lee S, Yoo J**, Plasmonic Annular Nanotrenches with 1 nm Nanogaps for Detection of SARS-CoV-2 Using SERS-Based Immunoassay. Nano Lett. 2024 Apr (IF: 10.8)
- Lee S, Yoo J** Elongated nanoporous Au networks improve somatic cell direct conversion into induced dopaminergic neurons for Parkinson's disease therapy. Acta biomaterialia. 2022 Aug (IF:10.633)